Opsenica Igor, Terzić Natasa, Opsenica Dejan, Angelovski Goran, Lehnig Manfred, Eilbracht Peter, Tinant Bernard, Juranić Zorica, Smith Kirsten S, Yang Young S, Diaz Damaris S, Smith Philip L, Milhous Wilbur K, Doković Dejan, Solaja Bogdan A
Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro.
J Med Chem. 2006 Jun 29;49(13):3790-9. doi: 10.1021/jm050966r.
Mixed tetraoxanes 5a and 13 synthesized from cholic acid and 4-oxocyclohexanecarboxylic acid were as active as artemisinin against chloroquine-susceptible, chloroquine-resistant, and multidrug-resistant Plasmodium falciparum strains (IC50, IC90). Most active 13 is metabolically stable in in vitro metabolism studies. In vivo studies on tetraoxanes with a C(4' ') methyl group afforded compound 15, which cured 4/5 mice at 600 and 200 mg.kg-1.day-1, and 2/5 mice at 50 mg.kg-1.day-1, showing no toxic effects. Tetraoxane 19 was an extremely active antiproliferative with LC50 of 17 nM and maximum tolerated dose of 400 mg/kg. In Fe(II)-induced scission of tetraoxane antimalarials only RO* radicals were detected by EPR experiments. This finding and the indication of Fe(IV)=O species led us to propose that RO* radicals are probably capable of inducing the parasite's death. Our results suggest that C radicals are possibly not the only lethal species derived from peroxide prodrug antimalarials, as currently believed.
由胆酸和4-氧代环己烷羧酸合成的混合四氧杂环烷5a和13对氯喹敏感、氯喹耐药和多药耐药的恶性疟原虫菌株(IC50、IC90)的活性与青蒿素相当。活性最高的13在体外代谢研究中代谢稳定。对具有C(4'')甲基的四氧杂环烷进行的体内研究得到了化合物15,该化合物在600和200mg.kg-1.day-1剂量下使4/5的小鼠治愈,在50mg.kg-1.day-1剂量下使2/5的小鼠治愈,且无毒性作用。四氧杂环烷19是一种极具活性的抗增殖剂,LC50为17 nM,最大耐受剂量为400mg/kg。在铁(II)诱导的四氧杂环烷抗疟药断裂过程中,通过电子顺磁共振实验仅检测到RO自由基。这一发现以及铁(IV)=O物种的迹象使我们提出,RO自由基可能能够导致寄生虫死亡。我们的结果表明,碳自由基可能并非如目前所认为的那样是过氧化物前药抗疟药产生的唯一致死物种。